Works matching IS 03407004 AND DT 2019 AND VI 68 AND IP 3

Results: 16

Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 341, doi. 10.1007/s00262-019-02310-2

By:

Nadal, Ernest;
Massuti, Bartomeu;
Dómine, Manuel;
García-Campelo, Rosario;
Cobo, Manuel;
Felip, Enriqueta

Publication type:

Article

Correction to: CD73 expression in normal and pathological human hepatobiliopancreatic tissues.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 529, doi. 10.1007/s00262-019-02309-9

By:

Sciarra, Amedeo;
Monteiro, Inês;
Ménétrier-Caux, Christine;
Caux, Christophe;
Gilbert, Benoit;
Halkic, Nermin;
La Rosa, Stefano;
Romero, Pedro;
Sempoux, Christine;
de Leval, Laurence

Publication type:

Article

STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 489, doi. 10.1007/s00262-019-02301-3

By:

Andersen, Morten Nørgaard;
Etzerodt, Anders;
Graversen, Jonas H.;
Holthof, Lisa C.;
Moestrup, Søren K.;
Hokland, Marianne;
Møller, Holger J.

Publication type:

Article

Chronic retroviral infection of mice promotes tumor development, but CD137 agonist therapy restores effective tumor immune surveillance.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 479, doi. 10.1007/s00262-019-02300-4

By:

Malyshkina, Anna;
Littwitz-Salomon, Elisabeth;
Sutter, Kathrin;
Ross, Jean Alexander;
Paschen, Annette;
Windmann, Sonja;
Schimmer, Simone;
Dittmer, Ulf

Publication type:

Article

The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 455, doi. 10.1007/s00262-018-02294-5

By:

Sultan, Hussein;
Kumai, Takumi;
Nagato, Toshihiro;
Wu, Juan;
Salazar, Andres M.;
Celis, Esteban

Publication type:

Article

Distinct immunological properties of the two histological subtypes of adenocarcinoma of the ampulla of Vater.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 443, doi. 10.1007/s00262-018-02293-6

By:

Kim, Min Hwan;
Jang, Mi;
Kim, Hoguen;
Lee, Woo Jung;
Kang, Chang Moo;
Choi, Hye Jin

Publication type:

Article

CD73 expression in normal and pathological human hepatobiliopancreatic tissues.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 467, doi. 10.1007/s00262-018-2290-1

By:

Sciarra, Amedeo;
Monteiro, Inês;
Ménétrier-Caux, Christine;
Caux, Christophe;
Gilbert, Benoit;
Halkic, Nermin;
La Rosa, Stefano;
Romero, Pedro;
Sempoux, Christine;
de Leval, Laurence

Publication type:

Article

Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 433, doi. 10.1007/s00262-018-2289-7

By:

Zhou, Rui;
Zhang, Jingwen;
Zeng, Dongqiang;
Sun, Huiying;
Rong, Xiaoxiang;
Shi, Min;
Bin, Jianping;
Liao, Yulin;
Liao, Wangjun

Publication type:

Article

The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 503, doi. 10.1007/s00262-018-2288-8

By:

Huijts, Charlotte M.;
Lougheed, Sinéad M.;
Bodalal, Zuhir;
van Herpen, Carla M.;
Hamberg, Paul;
Tascilar, Metin;
Haanen, John B.;
Verheul, Henk M.;
de Gruijl, Tanja D.;
van der Vliet, Hans J.;
for the Dutch WIN-O Consortium

Publication type:

Article

Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 517, doi. 10.1007/s00262-018-2287-9

By:

Chiappori, Alberto A.;
Williams, Charles C.;
Gray, Jhanelle E.;
Tanvetyanon, Tawee;
Haura, Eric B.;
Creelan, Ben C.;
Thapa, Ram;
Chen, Dung-Tsa;
Simon, George R.;
Bepler, Gerold;
Gabrilovich, Dmitry I.;
Antonia, Scott J.

Publication type:

Article

Identification and characterization of an alternative cancer-derived PD-L1 splice variant.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 407, doi. 10.1007/s00262-018-2284-z

By:

Hassounah, Nadia B.;
Malladi, Venkat S.;
Huang, Yi;
Freeman, Samuel S.;
Beauchamp, Ellen M.;
Koyama, Shohei;
Souders, Nicholas;
Martin, Sunil;
Dranoff, Glenn;
Wong, Kwok-Kin;
Pedamallu, Chandra S.;
Hammerman, Peter S.;
Akbay, Esra A.

Publication type:

Article

Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 379, doi. 10.1007/s00262-018-2283-0

By:

Llopiz, Diana;
Ruiz, Marta;
Villanueva, Lorea;
Iglesias, Tamara;
Silva, Leyre;
Egea, Josune;
Lasarte, Juan J.;
Pivette, Perrine;
Trochon-Joseph, Véronique;
Vasseur, Bérangère;
Dixon, Graham;
Sangro, Bruno;
Sarobe, Pablo

Publication type:

Article

A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 421, doi. 10.1007/s00262-018-2282-1

By:

Mahoney, Kathleen M.;
Shukla, Sachet A.;
Patsoukis, Nikolaos;
Chaudhri, Apoorvi;
Browne, Edward P.;
Arazi, Arnon;
Eisenhaure, Thomas M.;
Pendergraft, William F.;
Hua, Ping;
Pham, Hung C.;
Bu, Xia;
Zhu, Baogong;
Hacohen, Nir;
Fritsch, Edward F.;
Boussiotis, Vassiliki A.;
Wu, Catherine J.;
Freeman, Gordon J.

Publication type:

Article

CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 365, doi. 10.1007/s00262-018-2281-2

By:

Hu, Wanghong;
Zi, Zhenguo;
Jin, Yanling;
Li, Gaoxin;
Shao, Kang;
Cai, Qiliang;
Ma, Xiaojing;
Wei, Fang

Publication type:

Article

Ex vivo conditioning with IL-12 protects tumor-infiltrating CD8<sup>+</sup> T cells from negative regulation by local IFN-γ.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 395, doi. 10.1007/s00262-018-2280-3

By:

Lin, Lin;
Rayman, Patricia;
Pavicic, Paul G.;
Tannenbaum, Charles;
Hamilton, Thomas;
Montero, Alberto;
Ko, Jennifer;
Gastman, Brian;
Finke, James;
Ernstoff, Marc;
Diaz-Montero, C. Marcela

Publication type:

Article

The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 353, doi. 10.1007/s00262-018-2271-4

By:

Chang, Boyang;
Huang, Tao;
Wei, Huajun;
Shen, Lujun;
Zhu, Duo;
He, Wenjun;
Chen, Qifeng;
Zhang, Huihua;
Li, Yunjian;
Huang, Ruopan;
Li, Wang;
Wu, Peihong

Publication type:

Article